Siren Biotechnology
San Francisco
About Siren Biotechnology
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transforms how tumor cells are eliminated and anti-tumor immunity is stimulated.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $23.6M
- Funding stage: Seed
- Last round: Grant (Jun 2024)
- Website: sirenbiotechnology.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/siren-biotechnology-75862 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.